Seoul: South Korean biotech firm Cellid on Tuesday announced that it will sell stock to raise 24.2 billion won (US$16.6 million). The proceeds from the stock sale will be used mainly to finance its operations.
According to Yonhap News Agency, the company will issue 8.4 million common shares at a price of 2,875 won per share. The stock will be sold to the firm's shareholders.